0001493152-20-009278.txt : 20200518
0001493152-20-009278.hdr.sgml : 20200518
20200518100050
ACCESSION NUMBER: 0001493152-20-009278
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200514
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEPORE PATRICK G
CENTRAL INDEX KEY: 0001055404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38022
FILM NUMBER: 20888302
MAIL ADDRESS:
STREET 1: 17-17 ROUTE 208 N
CITY: FAIRLAWN
STATE: NJ
ZIP: 07410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc.
CENTRAL INDEX KEY: 0001582554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463011414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-443-1860
MAIL ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
ownership.xml
X0306
4
2020-05-14
0
0001582554
Matinas BioPharma Holdings, Inc.
MTNB
0001055404
LEPORE PATRICK G
C/O MATINAS BIOPHARMA HOLDINGS, INC.
1545 ROUTE 206 SOUTH SUITE 302
BEDMINSTER,
NJ
07921
1
0
0
0
Common Stock, par value $0.0001 per share
2020-05-14
4
P
0
100000
0.7305
A
400000
D
The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.7248 to $0.7399, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein.
/s/ Keith A. Kucinski, attorney-in fact for Patrick G. LePore
2020-05-18